178 related articles for article (PubMed ID: 34915912)
1. Methylation-derived inflammatory measures and lung cancer risk and survival.
Zhao N; Ruan M; Koestler DC; Lu J; Salas LA; Kelsey KT; Platz EA; Michaud DS
Clin Epigenetics; 2021 Dec; 13(1):222. PubMed ID: 34915912
[TBL] [Abstract][Full Text] [Related]
2. Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers.
Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
Cancer Prev Res (Phila); 2018 Nov; 11(11):727-734. PubMed ID: 30254071
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.
Ambatipudi S; Langdon R; Richmond RC; Suderman M; Koestler DC; Kelsey KT; Kazmi N; Penfold C; Ho KM; McArdle W; Ring SM; Pring M; Waterboer T; Pawlita M; Gaunt TR; Davey Smith G; Thomas S; Ness AR; Relton CL
Oral Oncol; 2018 Oct; 85():87-94. PubMed ID: 30220325
[TBL] [Abstract][Full Text] [Related]
4. DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.
Koestler DC; Usset J; Christensen BC; Marsit CJ; Karagas MR; Kelsey KT; Wiencke JK
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):328-338. PubMed ID: 27965295
[No Abstract] [Full Text] [Related]
5. Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer.
Grieshober L; Graw S; Barnett MJ; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
Cancer Causes Control; 2021 Nov; 32(11):1227-1236. PubMed ID: 34236573
[TBL] [Abstract][Full Text] [Related]
6. Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.
Wiencke JK; Koestler DC; Salas LA; Wiemels JL; Roy RP; Hansen HM; Rice T; McCoy LS; Bracci PM; Molinaro AM; Kelsey KT; Wrensch MR; Christensen BC
Clin Epigenetics; 2017; 9():10. PubMed ID: 28184256
[TBL] [Abstract][Full Text] [Related]
7. AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality.
Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
BMC Cancer; 2020 Sep; 20(1):905. PubMed ID: 32962699
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
[TBL] [Abstract][Full Text] [Related]
9. Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Clin Epigenetics; 2022 Jan; 14(1):14. PubMed ID: 35063012
[TBL] [Abstract][Full Text] [Related]
10. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.
Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H
Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915
[TBL] [Abstract][Full Text] [Related]
11. A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
Sandoval J; Mendez-Gonzalez J; Nadal E; Chen G; Carmona FJ; Sayols S; Moran S; Heyn H; Vizoso M; Gomez A; Sanchez-Cespedes M; Assenov Y; Müller F; Bock C; Taron M; Mora J; Muscarella LA; Liloglou T; Davies M; Pollan M; Pajares MJ; Torre W; Montuenga LM; Brambilla E; Field JK; Roz L; Lo Iacono M; Scagliotti GV; Rosell R; Beer DG; Esteller M
J Clin Oncol; 2013 Nov; 31(32):4140-7. PubMed ID: 24081945
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid Arthritis.
Ambatipudi S; Sharp GC; Clarke SLN; Plant D; Tobias JH; Evans DM; Barton A; Relton CL
J Immunol Res; 2018; 2018():2624981. PubMed ID: 30186880
[TBL] [Abstract][Full Text] [Related]
13. Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study.
Dugué PA; Bassett JK; Wong EM; Joo JE; Li S; Yu C; Schmidt DF; Makalic E; Doo NW; Buchanan DD; Hodge AM; English DR; Hopper JL; Giles GG; Southey MC; Milne RL
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442664
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation-based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies.
Dugué PA; Bassett JK; Joo JE; Jung CH; Ming Wong E; Moreno-Betancur M; Schmidt D; Makalic E; Li S; Severi G; Hodge AM; Buchanan DD; English DR; Hopper JL; Southey MC; Giles GG; Milne RL
Int J Cancer; 2018 Apr; 142(8):1611-1619. PubMed ID: 29197076
[TBL] [Abstract][Full Text] [Related]
15. Smoking-associated DNA methylation markers predict lung cancer incidence.
Zhang Y; Elgizouli M; Schöttker B; Holleczek B; Nieters A; Brenner H
Clin Epigenetics; 2016; 8():127. PubMed ID: 27924164
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.
Pine SR; Mechanic LE; Enewold L; Chaturvedi AK; Katki HA; Zheng YL; Bowman ED; Engels EA; Caporaso NE; Harris CC
J Natl Cancer Inst; 2011 Jul; 103(14):1112-22. PubMed ID: 21685357
[TBL] [Abstract][Full Text] [Related]
18. SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis.
Zhang R; Lai L; Dong X; He J; You D; Chen C; Lin L; Zhu Y; Huang H; Shen S; Wei L; Chen X; Guo Y; Liu L; Su L; Shafer A; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
Mol Oncol; 2019 May; 13(5):1235-1248. PubMed ID: 30924596
[TBL] [Abstract][Full Text] [Related]
19. Association of
Yu C; Hodge AM; Wong EM; Joo JE; Makalic E; Schmidt D; Buchanan DD; Hopper JL; Giles GG; Southey MC; Dugué PA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943892
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.
Ji X; Lin L; Shen S; Dong X; Chen C; Li Y; Zhu Y; Huang H; Chen J; Chen X; Wei L; He J; Duan W; Su L; Jiang Y; Fan J; Guan J; You D; Shafer A; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Zhang R; Chen F; Christiani DC
Mol Oncol; 2020 Nov; 14(11):2759-2774. PubMed ID: 33448640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
